PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION

PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION

PURPOSE:To obtain a peroral pharmaceutical preparation, containing ultrafine powder of a specific phosphonic acid diester derivative as an active ingredient, having stable and high bioavailability and useful as a pharmaceutical preparation for treating hyperlipemia. CONSTITUTION:This pharmaceutical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OBATA HIDEKI, ARITA SHIGEAKI
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OBATA HIDEKI
ARITA SHIGEAKI
description PURPOSE:To obtain a peroral pharmaceutical preparation, containing ultrafine powder of a specific phosphonic acid diester derivative as an active ingredient, having stable and high bioavailability and useful as a pharmaceutical preparation for treating hyperlipemia. CONSTITUTION:This pharmaceutical preparation contains ultrafine powder (preferably having
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH07291869A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH07291869A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH07291869A3</originalsourceid><addsrcrecordid>eNrjZDAK8HAM8nV0dg0N8XR29FEICHINcAxyDPH091Nw8w9S8A8CCjq6-Hr6eQaHQMR5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8V4CHgbmRpaGFmaWjMTFqAKIHJ3I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION</title><source>esp@cenet</source><creator>OBATA HIDEKI ; ARITA SHIGEAKI</creator><creatorcontrib>OBATA HIDEKI ; ARITA SHIGEAKI</creatorcontrib><description>PURPOSE:To obtain a peroral pharmaceutical preparation, containing ultrafine powder of a specific phosphonic acid diester derivative as an active ingredient, having stable and high bioavailability and useful as a pharmaceutical preparation for treating hyperlipemia. CONSTITUTION:This pharmaceutical preparation contains ultrafine powder (preferably having &lt;=5mum average particle diameter measured by a microscopic image processor) of a diphosphonic acid diester derivative expressed by the formula (R is a lower alkyl; X is a halogen) {preferably diethyl 4-[(4-bromo-2- cyanophenyl)carbamoyl]benzylphosphonate} as an active ingredient. A powder, a fine granule, a granule, a capsule, a tablet, a syrup, etc., are cited as the form and the daily dose thereof is preferably 0.05-80mg/kg.</description><edition>6</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951107&amp;DB=EPODOC&amp;CC=JP&amp;NR=H07291869A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19951107&amp;DB=EPODOC&amp;CC=JP&amp;NR=H07291869A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OBATA HIDEKI</creatorcontrib><creatorcontrib>ARITA SHIGEAKI</creatorcontrib><title>PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION</title><description>PURPOSE:To obtain a peroral pharmaceutical preparation, containing ultrafine powder of a specific phosphonic acid diester derivative as an active ingredient, having stable and high bioavailability and useful as a pharmaceutical preparation for treating hyperlipemia. CONSTITUTION:This pharmaceutical preparation contains ultrafine powder (preferably having &lt;=5mum average particle diameter measured by a microscopic image processor) of a diphosphonic acid diester derivative expressed by the formula (R is a lower alkyl; X is a halogen) {preferably diethyl 4-[(4-bromo-2- cyanophenyl)carbamoyl]benzylphosphonate} as an active ingredient. A powder, a fine granule, a granule, a capsule, a tablet, a syrup, etc., are cited as the form and the daily dose thereof is preferably 0.05-80mg/kg.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAK8HAM8nV0dg0N8XR29FEICHINcAxyDPH091Nw8w9S8A8CCjq6-Hr6eQaHQMR5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8V4CHgbmRpaGFmaWjMTFqAKIHJ3I</recordid><startdate>19951107</startdate><enddate>19951107</enddate><creator>OBATA HIDEKI</creator><creator>ARITA SHIGEAKI</creator><scope>EVB</scope></search><sort><creationdate>19951107</creationdate><title>PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION</title><author>OBATA HIDEKI ; ARITA SHIGEAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH07291869A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>OBATA HIDEKI</creatorcontrib><creatorcontrib>ARITA SHIGEAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OBATA HIDEKI</au><au>ARITA SHIGEAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION</title><date>1995-11-07</date><risdate>1995</risdate><abstract>PURPOSE:To obtain a peroral pharmaceutical preparation, containing ultrafine powder of a specific phosphonic acid diester derivative as an active ingredient, having stable and high bioavailability and useful as a pharmaceutical preparation for treating hyperlipemia. CONSTITUTION:This pharmaceutical preparation contains ultrafine powder (preferably having &lt;=5mum average particle diameter measured by a microscopic image processor) of a diphosphonic acid diester derivative expressed by the formula (R is a lower alkyl; X is a halogen) {preferably diethyl 4-[(4-bromo-2- cyanophenyl)carbamoyl]benzylphosphonate} as an active ingredient. A powder, a fine granule, a granule, a capsule, a tablet, a syrup, etc., are cited as the form and the daily dose thereof is preferably 0.05-80mg/kg.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPH07291869A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T22%3A05%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OBATA%20HIDEKI&rft.date=1995-11-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH07291869A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true